Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by lscfaon Aug 11, 2015 9:31am
160 Views
Post# 24006313

RE:RE:Earnings out...

RE:RE:Earnings out...Accounting distortions are misleading. Net rev growth for the qtr was 32% but gross rev growth was 90%. Also cash flow from operations was 81%......  
lscfa wrote: Since results fluctuated with timing of inventory MSL should have emphasized growth rates for longer periods.

e.g.

Q3 yoy rev growth 32%
6 month yoy rev growth 61%
9 month yoy rev growth 63%


<< Previous
Bullboard Posts
Next >>